The Problem

Some people report persistent, disabling symptoms that begin after COVID-19 vaccination. How many is uncertain: one analysis estimated a prevalence of 0.003% in the general population from pharmacovigilance data, and 0.9% in young and middle-aged people from occupational surveillance studies (Platschek & Boege, Vaccines 2024). Post-Acute COVID-19 Vaccination Syndrome (PACVS), also known as post-vaccination syndrome (PVS), PCVS and Post-Vac-Syndrom, presents with chronic fatigue, cognitive impairment, neuropathy, dysautonomia, exercise intolerance, and multi-organ dysfunction. Studies in patients have reported autoantibody, cytokine and spike-protein findings, but these await replication, and there is still no formal case definition, no validated diagnostic panel, and no completed clinical trial for this condition. How strong the evidence is for each proposed mechanism →

The Gap

What's Needed Current Status
Formal diagnostic criteria Does not exist
Validated biomarker panel Does not exist
International research network Does not exist

The summit, held in June 2026, was convened to address all three.

The Approach

We employ a modified Delphi consensus process — the gold-standard method for establishing expert agreement on medical questions where evidence is emerging but incomplete:

  • Pre-meeting anonymous survey (Round 1): Panelists rate candidate diagnostic criteria, biomarkers, and research priorities on standardized Likert scales.
  • Half-day virtual workshop: Structured breakout groups address contested items. Facilitated discussion ensures all voices are heard.
  • Post-meeting survey (Round 2): Panelists re-rate items in light of the group discussion.
  • Consensus thresholds: Results are reported per ACCORD (Accurate Consensus Reporting Document) guidelines, with pre-specified agreement thresholds.

Who Is Behind This

MH

Matthew Thomas J Halma, MSc, MBA

Director, Open Source Medicine Foundation

Matthew Halma is a researcher with a background in computational biophysics, drug discovery, and clinical research methodology. His peer-reviewed publications on spike protein pathology, metabolic modulation, and post-vaccination syndrome have appeared in Frontiers in Medicine, Advances in Virology, Microorganisms, and other journals.

· Google Scholar Profile →

Related Published Work by the Organiser

Peer-reviewed papers on PACVS co-authored by the summit organiser. These are not summit outputs.

  • Halma M, Varon J. Restoring trust in vaccination: listening to patients and acknowledging Post-Acute COVID Vaccine Syndrome. Frontiers in Medicine, 2025. doi:10.3389/fmed.2025.1688170
  • Halma M, Varon J. Breaking the silence: Recognizing post-vaccination syndrome. Heliyon, 2025. doi:10.1016/j.heliyon.2025.e43478
  • Selem E, Raszek M, Varon J, Halma M. The persistence of COVID-19 vaccine artifacts in bodily fluids and tissues: a systematic review. Future Journal of Pharmaceutical Sciences, 2026. doi:10.1186/s43094-026-00939-2
  • Halma M, Dhillon S, Gracidas C, Hassaan S, Bellavite P, Di Fede G, Varon J. Autoimmunity, Vascular Dysfunction and Metabolic Alterations: A Trifecta of Impacts in Postacute COVID-19 Vaccination Syndrome (PACVS). Book chapter, IntechOpen, 2026. doi:10.5772/intechopen.1014628

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation

The central hub for open-source medical research and collaborative science.

Research Platform

Open-access research infrastructure supporting data sharing, methodology, and reproducibility.

SpikeProtein.site

A comprehensive resource on spike protein pathology, persistence, and therapeutic approaches.

Vaccine Data Navigator

Data-driven tools and resources for navigating vaccine safety and efficacy information.

PACVS Research Summit

Consensus-driven PACVS research linking clinicians, scientists, and patient partners in the search for rigorous diagnosis and treatment evidence.